Zhejiang Runyang New Material Technology Résultats passés
Passé contrôle des critères 4/6
Zhejiang Runyang New Material Technology's earnings have been declining at an average annual rate of -34.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 4.4% per year. Zhejiang Runyang New Material Technology's return on equity is 2.9%, and it has net margins of 10.2%.
Informations clés
-34.2%
Taux de croissance des bénéfices
-41.7%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.1% |
| Taux de croissance des recettes | -4.4% |
| Rendement des fonds propres | 2.9% |
| Marge nette | 10.2% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
There's Reason For Concern Over Zhejiang Runyang New Material Technology Co., Ltd.'s (SZSE:300920) Price
Sep 27
Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Surges 29% Yet Its Low P/E Is No Reason For Excitement
May 21Be Wary Of Zhejiang Runyang New Material Technology (SZSE:300920) And Its Returns On Capital
Apr 23Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Investors Are Less Pessimistic Than Expected
Mar 06Ventilation des recettes et des dépenses
Comment Zhejiang Runyang New Material Technology gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 408 | 42 | 49 | 12 |
| 30 Jun 24 | 406 | 51 | 48 | 11 |
| 31 Mar 24 | 389 | 59 | 47 | 10 |
| 31 Dec 23 | 359 | 42 | 45 | 11 |
| 30 Sep 23 | 324 | 32 | 41 | 15 |
| 30 Jun 23 | 299 | 16 | 39 | 16 |
| 31 Mar 23 | 336 | 13 | 41 | 19 |
| 01 Jan 23 | 390 | 33 | 43 | 22 |
| 30 Sep 22 | 443 | 36 | 48 | 27 |
| 30 Jun 22 | 508 | 65 | 53 | 28 |
| 31 Mar 22 | 514 | 81 | 47 | 27 |
| 01 Jan 22 | 502 | 90 | 44 | 23 |
| 30 Sep 21 | 496 | 107 | 36 | 19 |
| 30 Jun 21 | 486 | 121 | 31 | 18 |
| 31 Mar 21 | 465 | 127 | 34 | 17 |
| 31 Dec 20 | 434 | 127 | 30 | 16 |
| 30 Sep 20 | 403 | 124 | 57 | 23 |
| 31 Dec 19 | 365 | 116 | 32 | 12 |
| 31 Dec 18 | 325 | 87 | 23 | 10 |
| 31 Dec 17 | 168 | 21 | 34 | 8 |
| 30 Jun 17 | 99 | 16 | 11 | 0 |
| 31 Mar 17 | 77 | 11 | 10 | 0 |
| 31 Dec 16 | 56 | 6 | 10 | 0 |
| 30 Sep 16 | 47 | 5 | 9 | 0 |
| 30 Jun 16 | 39 | 3 | 9 | 0 |
| 31 Mar 16 | 35 | 2 | 8 | 0 |
| 31 Dec 15 | 31 | 2 | 7 | 0 |
| 31 Dec 14 | 22 | 0 | 4 | 0 |
| 31 Dec 13 | 16 | 0 | 3 | 0 |
Des revenus de qualité: 300920 has high quality earnings.
Augmentation de la marge bénéficiaire: 300920's current net profit margins (10.2%) are higher than last year (9.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 300920's earnings have declined by 34.2% per year over the past 5 years.
Accélération de la croissance: 300920's earnings growth over the past year (29.1%) exceeds its 5-year average (-34.2% per year).
Bénéfices par rapport au secteur d'activité: 300920 earnings growth over the past year (29.1%) exceeded the Chemicals industry -3.8%.
Rendement des fonds propres
ROE élevé: 300920's Return on Equity (2.9%) is considered low.